Full Press Release Details
Secretary / Executive Director
Exchange of India Ltd.
New York Stock Exchange Inc.
This is to inform you that Mr. Hans Peter Hasler has been appointed as an Additional Director, categorized as Independent on the Board of
Dr. Reddy s Laboratories Limited, effective June 17, 2016.
Mr. Hans Peter Hasler is the Principal of HPH Management GmbH,
K ssnacht, Switzerland, the Chairman of HBM Healthcare Investments AG in Zug since June 2009 and Founder of Vicarius Pharma Limited AG, in Switzerland. He is also the Chairman of the Board of Medical Imaging Analysis Center (MIAC) of the
University Hospital, Basel, a non-profit organization, since December 2012 and a Director on the Board of Patheon Inc., USA and AOP Orphan Pharmaceuticals, Austria.
Mr. Hasler holds a Federal Swiss Commercial Diploma from Canton of Bern, Switzerland (Kaufmann) and Diploma in Business Management from Swiss
Institute of Business, Zurich.
Mr. Hasler is an experienced Pharma and Biotech Executive and has an international track record and in-depth
operational, commercial and general management expertise. He also acts as top-level advisor to the life-science industry. In his career, he has managed the growth of leading players in the pharmaceutical industry and successfully launched several
He was the Chief Operating Officer of Biogen Idefac Inc., Cambridge/USA between 2001 and mid-2009. He also spearheaded various
leadership positions in an executive role including Head of Biogen s International Business.
Between 1993 and 2001, he held various positions in
Wyeth such as Managing Director of Wyeth (Switzerland, Austria and Eastern Central Europe); Managing Director of Wyeth Group (Germany) and Senior Vice President of Global Marketing and Chief Marketing Officer at Wyeth s Headquarters in
This is for your information and records.